Brought to you by 
Genencor nets $135mm in 8mm share IPO
28 Aug 2000
Executive Summary
Genencor (currently makes and sells genetically altered enzymes for industrial chemicals and agriculture uses; is expanding into health care) netted $134.6mm in its initial public offering of 8mm common shares, including the overalottment, at $18 each.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genencor nets $135mm in 8mm share IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice